AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+14.75%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.25B
AUM Growth
+$1.25B
(+16%)
Cap. Flow
-$23.1M
Cap. Flow
% of AUM
-1.85%
Top 10 Holdings %
Top 10 Hldgs %
36.71%
Holding
97
New
32
Increased
16
Reduced
15
Closed
25
Top Buys
| 1 |
Supernus Pharmaceuticals
SUPN
|
$40.6M |
| 2 |
Williams-Sonoma
WSM
|
$32.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
$32.1M |
| 4 |
Deckers Outdoor
DECK
|
$31.1M |
| 5 |
PTC Therapeutics
PTCT
|
$29.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$50.8M |
| 2 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$42.4M |
| 3 |
Energizer
ENR
|
$34.9M |
| 4 |
Assembly Biosciences
ASMB
|
$26.8M |
| 5 |
Foot Locker
FL
|
$26.5M |
Sector Composition
| 1 | Healthcare | 58.42% |
| 2 | Consumer Discretionary | 23.75% |
| 3 | Consumer Staples | 8.12% |
| 4 | Technology | 3.92% |
| 5 | Industrials | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $111M | 6.43% | 20,683,233 | – | – |
|
|
AMAG
2
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $49.4M | 2.85% | 4,060,000 | – | – |
|
3
Vanda Pharmaceuticals
VNDA
$279M
| $46.4M | 2.68% | 2,828,000 -720,000 | -20% | -$11.8M |
|
|
4
Supernus Pharmaceuticals
SUPN
$2.53B
| $40.6M | 2.34% | +1,712,000 | New | +$40.6M |
|
5
Biogen
BIIB
$19.4B
| $38M | 2.19% | 128,000 -20,000 | -14% | -$5.93M |
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $37.5M | 2.17% | 100,000 -48,000 | -32% | -$18M |
|
|
7
PTC Therapeutics
PTCT
$3.92B
| $36.4M | 2.1% | 758,000 +622,000 | +457% | +$29.9M |
|
|
BHVN
8
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $33.3M | 1.92% | 612,000 +34,000 | +6% | +$1.85M |
|
|
9
Williams-Sonoma
WSM
$23.1B
| $32.8M | 1.89% | +447,206 | New | +$32.8M |
|
|
10
Bristol-Myers Squibb
BMY
$96B
| $32.1M | 1.85% | +500,000 | New | +$32.1M |
|
|
11
Deckers Outdoor
DECK
$17.7B
| $31.1M | 1.79% | +184,100 | New | +$31.1M |
|
|
BLUE
12
DELISTED
bluebird bio
BLUE
| $29.5M | 1.7% | +336,000 | New | +$29.5M |
|
13
AutoZone
AZO
$70.2B
| $29.4M | 1.69% | +24,651 | New | +$29.4M |
|
14
Chipotle Mexican Grill
CMG
$56.5B
| $28.2M | 1.63% | 33,742 +3,742 | +12% | +$3.13M |
|
15
Dropbox
DBX
$7.84B
| $26.1M | 1.51% | 1,458,000 +458,000 | +46% | +$8.2M |
|
16
Central Garden & Pet Class A
CENTA
$2.08B
| $25.8M | 1.49% | +878,000 | New | +$25.8M |
|
17
Envista
NVST
$3.52B
| $25.1M | 1.45% | +848,000 | New | +$25.1M |
|
18
Enanta Pharmaceuticals
ENTA
$180M
| $24.3M | 1.4% | 393,895 -186,105 | -32% | -$11.5M |
|
19
Incyte
INCY
$16.5B
| $24M | 1.39% | 275,000 -153,000 | -36% | -$13.4M |
|
20
Frontdoor
FTDR
$4.43B
| $23.7M | 1.37% | 500,000 +108,000 | +28% | +$5.12M |
|
|
21
Assembly Biosciences
ASMB
$190M
| $23.7M | 1.36% | 1,156,000 -1,312,000 | -53% | -$26.8M |
|
|
AVYA
22
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $22.8M | 1.32% | 1,692,000 +1,172,000 | +225% | +$15.8M |
|
23
Voyager Therapeutics
VYGR
$186M
| $22.7M | 1.31% | 1,624,000 +528,000 | +48% | +$7.37M |
|
24
Kraft Heinz
KHC
$33.1B
| $22.2M | 1.28% | 690,000 -810,000 | -54% | -$26M |
|
25
Estee Lauder
EL
$33B
| $20.7M | 1.19% | +100,000 | New | +$20.7M |
|